ZA772612B - Pharmaceutical compositions - Google Patents

Pharmaceutical compositions

Info

Publication number
ZA772612B
ZA772612B ZA00772612A ZA772612A ZA772612B ZA 772612 B ZA772612 B ZA 772612B ZA 00772612 A ZA00772612 A ZA 00772612A ZA 772612 A ZA772612 A ZA 772612A ZA 772612 B ZA772612 B ZA 772612B
Authority
ZA
South Africa
Prior art keywords
pharmaceutical compositions
pharmaceutical
compositions
Prior art date
Application number
ZA00772612A
Other languages
English (en)
Inventor
G Durant
M Vickers
C Ganellin
Original Assignee
Smith Kline French Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smith Kline French Lab filed Critical Smith Kline French Lab
Publication of ZA772612B publication Critical patent/ZA772612B/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D295/00Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/08Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
    • C07D295/084Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
    • C07D295/088Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings to an acyclic saturated chain
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • A61P37/06Immunosuppressants, e.g. drugs for graft rejection
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C335/00Thioureas, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups
    • C07C335/30Isothioureas
    • C07C335/32Isothioureas having sulfur atoms of isothiourea groups bound to acyclic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/04Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D233/28Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/30Oxygen or sulfur atoms
    • C07D233/42Sulfur atoms

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Transplantation (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Steroid Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
ZA00772612A 1976-05-14 1977-05-02 Pharmaceutical compositions ZA772612B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB19994/76A GB1592453A (en) 1976-05-14 1976-05-14 Aminoalkyl esters of carbarimidothioic acid and compositions having immunosuppressant activity

Publications (1)

Publication Number Publication Date
ZA772612B true ZA772612B (en) 1978-04-26

Family

ID=10138568

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA00772612A ZA772612B (en) 1976-05-14 1977-05-02 Pharmaceutical compositions

Country Status (23)

Country Link
US (1) US4294854A (fr)
JP (1) JPS532420A (fr)
AR (1) AR218872A1 (fr)
AT (1) AT359521B (fr)
AU (1) AU509573B2 (fr)
BE (1) BE854553A (fr)
CA (1) CA1086758A (fr)
CH (1) CH620203A5 (fr)
DE (1) DE2721830A1 (fr)
DK (1) DK211277A (fr)
ES (1) ES458756A1 (fr)
FI (1) FI771400A (fr)
FR (2) FR2351098A1 (fr)
GB (1) GB1592453A (fr)
HU (1) HU174978B (fr)
IE (1) IE45144B1 (fr)
IL (1) IL52011A (fr)
LU (1) LU77332A1 (fr)
NL (1) NL7705331A (fr)
NO (1) NO771697L (fr)
PT (1) PT66509B (fr)
SE (1) SE7705658L (fr)
ZA (1) ZA772612B (fr)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0672244B2 (ja) * 1984-12-12 1994-09-14 三菱マテリアル株式会社 貴金属造粒装置
AU695120B2 (en) * 1993-06-07 1998-08-06 Baylor College Of Medicine Use of an MHC class I suppressor drug for the treatment of autoimmune diseases and transplantation rejection
AU3230895A (en) * 1994-08-18 1996-03-14 Chugai Seiyaku Kabushiki Kaisha Amino acid derivative having nitrogen monoxide synthetase inhibitor activity
US7645873B2 (en) * 2003-03-20 2010-01-12 The Scripps Research Institute 6″-amino-6″-deoxygalactosylceramides
EP2058011A1 (fr) * 2007-11-07 2009-05-13 Wittycell Cellule Nkt activant des antigènes et/ou médicaments à liaison gycolipids covalentyl
US9220767B2 (en) * 2008-10-08 2015-12-29 Abivax Vaccine composition for use against influenza

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2648710A (en) * 1950-09-22 1953-08-11 Hoffmann La Roche Bis-quaternary salts of 1:10-bis-(dialkylamino)-5:6-dithia-decane
US2813102A (en) * 1956-04-10 1957-11-12 American Home Prod 2-(di-lower alkylaminoethylmercapto)-imidazolines and their acid addition salts and preparation thereof
US4152453A (en) * 1975-12-01 1979-05-01 Smith Kline & French Laboratories Limited Pharmacologically active compounds and compositions and methods of use

Also Published As

Publication number Publication date
FR2351098A1 (fr) 1977-12-09
US4294854A (en) 1981-10-13
AU509573B2 (en) 1980-05-15
ATA318277A (de) 1980-04-15
FR2472935A1 (fr) 1981-07-10
IE45144L (en) 1977-11-14
DK211277A (da) 1977-11-15
BE854553A (fr) 1977-11-14
IL52011A (en) 1982-05-31
ES458756A1 (es) 1978-03-01
CA1086758A (fr) 1980-09-30
AR218872A1 (es) 1980-07-15
PT66509B (en) 1978-10-16
DE2721830A1 (de) 1977-11-24
FR2351098B1 (fr) 1982-06-18
CH620203A5 (fr) 1980-11-14
LU77332A1 (fr) 1977-08-29
NL7705331A (nl) 1977-11-16
PT66509A (en) 1977-06-01
SE7705658L (sv) 1977-11-15
HU174978B (hu) 1980-04-28
JPS532420A (en) 1978-01-11
NO771697L (no) 1977-11-15
GB1592453A (en) 1981-07-08
FI771400A (fr) 1977-11-15
AT359521B (de) 1980-11-10
IE45144B1 (en) 1982-06-30
AU2507977A (en) 1978-11-16

Similar Documents

Publication Publication Date Title
ZA771090B (en) Pharmaceutical compositions
ZA774920B (en) Pharmaceutical compositions
PT66622A (en) Pharmaceutical compositions
JPS52113976A (en) Pharmaceutical composition
JPS5362838A (en) Pharmaceutical composition
AU3111677A (en) Pharmaceutical compositions
ZA771003B (en) Pharmaceutical compositions containing pyrethrinoides
NZ183551A (en) Aminochromanols and pharmaceutical compositions containingthem
NZ184539A (en) 2-bromo-6-fluoro-n-2-imidazolidinylidene-benzamine pharmaceutical compositions
AU3152677A (en) Pharmaceutical composition
NZ186147A (en) Sterolin pharmaceutical compositions
AU2609277A (en) Pharmaceutical compositions
AU2649977A (en) Pharmaceutical composition
JPS5356634A (en) Pharmaceutical composition
NZ183549A (en) Amidinopencillanoyloxy-alkyl-amoxycillinates and pharmaceutical compositions
IL52103A0 (en) Pharmaceutical compositions containing naphthopyrane derivvatives
HK69380A (en) Pharmaceutical compositions
ZA772612B (en) Pharmaceutical compositions
AU2574877A (en) Pharmaceutical compositions
HK3984A (en) Pharmaceutical compositions
NZ183756A (en) Bis-penicillanoyloxy-alkanes and pharmaceutical compositions
JPS5283918A (en) Pharmaceutical composition
NZ183436A (en) Substituted phenylguanidines and pharmaceutical compositions
ZA771408B (en) Pharmaceutical compositions
JPS52122633A (en) Pharmaceutical composition